Placental DNA methylation changes in gestational diabetes mellitus

References

• Hod M, Kapur A, Sacks DA, et al. The international federation of gynecology and obstetrics (FIGO) initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet. 2015;131(Suppl 3):S173–211.
   Google Scholar
• Wong V, Lin A, Russell H. Adopting the new World Health Organization diagnostic criteria for gestational diabetes: how the prevalence changes in a high-risk region in Australia. Diabetes Res Clin Pract. 2017;129(2):148–153.
   Google Scholar
• Gao C, Sun X, Lu L, et al. Prevalence of gestational diabetes mellitus in mainland China: a systematic review and meta-analysis. J Diabetes Investig. 2019;10(1):154–162.
   Google Scholar
• Plows J, Stanley J, Baker P, et al. The pathophysiology of gestational diabetes mellitus. Int J Mol Sci. 2018;19(11):3342–3363.
   Google Scholar
• Bashir M, Aboulfotouh M, Dabbous Z, et al. Metformin-treated-GDM has lower risk of macrosomia compared to diet-treated GDM- a retrospective cohort study. J Matern Fetal Neonatal Med. 2020;33(14):2366–2371.
   Google Scholar
• Nguyen-Ngo C, Jayabalan N, Salomon C, et al. Molecular pathways disrupted by gestational diabetes mellitus. J Mol Endocrinol. 2019;63(3):R51–R72.
   Google Scholar
• Stacey T, Tennant P, McCowan L, et al. Gestational diabetes and the risk of late stillbirth: a case-control study from England, UK. Bjog. 2019;126(8):973–982.
   Google Scholar
• M RL, H SC, J EA, et al. Palmitate induces apoptotic cell death and inflammasome activation in human placental macrophages. Placenta. 2020;90(12):45–51.
   Google Scholar
• L BT, A GJ, C SA, et al. Gestational diabetes mellitus is associated with increased CD163 expression and iron storage in the placenta. Am J Reprod Immunol. 2018;80(4):e13020–e13043.
   Google Scholar
• Y CP, Chu A, W LW, et al. Prenatal growth patterns and birthweight are associated with differential dna methylation and gene expression of cardiometabolic risk genes in human placentas: a discovery-based approach. Reprod Sci. 2018;25(4):523–539.
   Google Scholar
• Lizárraga D, García-Gasca A. The placenta as a target of epigenetic alterations in women with gestational diabetes mellitus and potential implications for the offspring. Epigenomes. 2021;5(2):13–27.
   Google Scholar
• Lesseur C, Chen J. Adverse maternal metabolic intrauterine environment and placental epigenetics: implications for fetal metabolic programming. Curr Environ Health Rep. 2018;5(4):531–543.
   Google Scholar
• Haertle L, El Hajj N, Dittrich M, et al. Epigenetic signatures of gestational diabetes mellitus on cord blood methylation. Clin Epigenetics. 2017;9(1):28–30.
   Google Scholar
• Hivert MF, Cardenas A, Allard C, et al. Interplay of placental DNA methylation and maternal insulin sensitivity in pregnancy. Diabetes. 2020;69(3):484–492.
   Google Scholar
• Reichetzeder C, Putra S E D, Pfab T, et al. Increased global placental DNA methylation levels are associated with gestational diabetes. Clin Epigenetics. 2016;8(1):82–93.
   Google Scholar
• Chen C, Jiang Y, Yan T, et al. Placental maternally expressed gene 3 differentially methylated region methylation profile is associated with maternal glucose concentration and newborn birthweight. J Diabetes Investig. 2021;12(6):1074–1082.
   Google Scholar
• Finer S, Mathews C, Lowe R, et al. Maternal gestational diabetes is associated with genome-wide DNA methylation variation in placenta and cord blood of exposed offspring. Hum Mol Genet. 2015;24(11):3021–3029.
   Google Scholar
• Awamleh Z, Butcher DT, Hanley A, et al. Exposure to gestational diabetes mellitus (GDM) alters DNA methylation in placenta and fetal cord blood. Diabetes Res Clin Pract. 2021;174:108690–108701.
   Google Scholar
• Teng Y, Xuan S, Jiang M, et al. Expression of H(2)S in gestational diabetes mellitus and correlation analysis with inflammatory markers IL-6 and TNF-α. J Diabetes Res. 2020;2020(1):1–11.
   Google Scholar
• Jayawardane A, Patabendige M, Samaranayake D, et al. Hyperglycemia in pregnancy among South Asian women: a single tertiary care center experience from Colombo, Sri Lanka. Diabetes Res Clin Pract. 2018;145(1):138–145.
   Google Scholar
• Lee D, M KY, Jung K, et al. Alpha-mangostin improves insulin secretion and protects INS-1 cells from streptozotocin-induced damage. Int J Mol Sci. 2018;19(5):1484–1497.
   Google Scholar
• Xie X, Gao H, Zeng W, et al. Placental DNA methylation of peroxisome-proliferator-activated receptor-γ co-activator-1α promoter is associated with maternal gestational glucose level. Clin Sci (Lond). 2015;129(4):385–394.
   Google Scholar
• Zhang Q, Su R, Qin S, et al. High glucose increases IGF-2/H19 expression by changing DNA methylation in HTR8/SVneo trophoblast cells. Placenta. 2022;118:32–37.
   Google Scholar
• Pan X, Jin X, Wang J, et al. Placenta inflammation is closely associated with gestational diabetes mellitus. Am J Transl Res. 2021;13(5):4068–4079.
   Google Scholar
• Esser N, Legrand-Poels S, Piette J, et al. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. 2014;105(2):141–150.
   Google Scholar
• P DA, Chhun N, C TA, et al. Periodontal pathogens and gestational diabetes mellitus. J Dent Res. 2008;87(4):328–333.
   Google Scholar
• Esposito D, Koliopoulos M. G and Rittinger K.structural determinants of TRIM protein function. Biochem Soc Trans. 2017;45(1):183–191.
   Google Scholar
• Yang J, Fu Z, Zhang X, et al. TREM2 ectodomain and its soluble form in alzheimer’s disease. J Neuroinflammation. 2020;17(1):204–210.
   Google Scholar
• Yang W, Gu Z, Zhang H, et al. To TRIM the immunity: from innate to adaptive immunity. Front Immunol. 2020;11(1):02157–02168.
   Google Scholar
• Wang HT, Hur S. Substrate recognition by TRIM and TRIM-like proteins in innate immunity. Semin Cell Dev Biol. 2021;111(1):76–85.
   Google Scholar
• Meroni G. TRIM E3 ubiquitin ligases in rare genetic disorders. Adv Exp Med Biol. 2020;1233(1):311–325.
   Google Scholar
• Hatakeyama S. TRIM family proteins: roles in autophagy, immunity, and carcinogenesis. Trends Biochem Sci. 2017;42(4):297–311.
   Google Scholar
• Liu R, Chen Y, Shou T, et al. TRIM67 promotes NF‑κB pathway and cell apoptosis in GA‑13315‑treated lung cancer cells. Mol Med Rep. 2019;20(3):2936–2944.
   Google Scholar
• Baker RG, Hayden MS, Ghosh S. NF-κB, inflammation, and metabolic disease. Cell Metab. 2011;13(1):11–22.
   Google Scholar
• Sun SC. The non-canonical NF-κB pathway in immunity and inflammation. Nat Rev Immunol. 2017;17(9):545–558.
   Google Scholar
• E KA, Temprosa M, C KW, et al. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin. Diabetes. 2005;54(8):2404–2414.
   Google Scholar
• Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22(9):1462–1470.
   Google Scholar
• L CK, D WC, K SB, et al. Islet hypersensitivity to glucose is associated with disrupted oscillations and increased impact of proinflammatory cytokines in islets from diabetes-prone male mice. Endocrinology. 2016;157(5):1826–1838.
   Google Scholar
• Muhanhali D, Zhai T, Cai Z, et al. Lipoprotein(a) concentration is associated with risk of type 2 diabetes and cardiovascular events in a Chinese population with very high cardiovascular risk. Endocrine. 2020;69(1):63–72.
   Google Scholar
• Qi Q, Workalemahu T, Zhang C, et al. Genetic variants, plasma lipoprotein(a) levels, and risk of cardiovascular morbidity and mortality among two prospective cohorts of type 2 diabetes. Eur Heart J. 2012;33(3):325–334.
   Google Scholar
• Paige E, L MK, Tsimikas S, et al. Lipoprotein(a) and incident type-2 diabetes: results from the prospective Bruneck study and a meta-analysis of published literature. Cardiovasc Diabetol. 2017;16(1):38–44.
   Google Scholar
• K BE, M SB, V NZ, et al. Epigenetic regulation of placenta-specific 8 contributes to altered function of endothelial colony-forming cells exposed to intrauterine gestational diabetes mellitus. Diabetes. 2015;64(7):2664–2675.
   Google Scholar
• Thangaratinam S, Rogozinska E, Jolly K, et al. Effects of interventions in pregnancy on maternal weight and obstetric outcomes: meta-analysis of randomised evidence. BMJ. 2012;344:e2088.
   Google Scholar
• Rasmussen L, Poulsen CW, Kampmann U, et al. Diet and healthy lifestyle in the management of gestational diabetes mellitus. Nutrients. 2020;12(10):3050–3074.
   Google Scholar
• Villota SD, Toledo-Rodriguez M, Leach L. Compromised barrier integrity of human feto-placental vessels from gestational diabetic pregnancies is related to downregulation of occludin expression. Diabetologia. 2021;64(1):195–210.
   Google Scholar
• Kimura R, Lardenoije R, Tomiwa K, et al. Integrated DNA methylation analysis reveals a potential role for ANKRD30B in Williams syndrome. Neuropsychopharmacology. 2020;45(10):1627–1636.
   Google Scholar
• Yin Y, Morgunova E, Jolma A, et al. Impact of cytosine methylation on DNA binding specificities of human transcription factors. Science. 2017;356(6337):eaaj2239.
   Google Scholar
• Xu M, Qin J, Tsai SY, et al. The role of the orphan nuclear receptor COUP-TFII in tumorigenesis. Acta Pharmacol Sin. 2015;36(1):32–36.
   Google Scholar
• Bardoux P, Zhang P, Flamez D, et al. Essential role of chicken ovalbumin upstream promoter-transcription factor II in insulin secretion and insulin sensitivity revealed by conditional gene knockout. Diabetes. 2005May;545:1357–1363. PMID: 15855320
   Google Scholar
• Polvani S, Pepe S, Milani S, et al. COUP-TFII in health and disease. Cells. 2019;9(1):101.
   Google Scholar